β-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-α expression in adipocytes

European Journal of Pharmacology

Volumn 569, Issue 1-2, 2007, Pages 155-162

  Fu, Ling ^a   Isobe, Kazumasa ^a   Zeng, Qin ^a   Suzukawa, Kazumi ^a   Takekoshi, Kazuhiro ^a   Kawakami, Yasushi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

adrenoceptor; 3T3 L1 adipocyte; Adiponectin; Adiponectin receptor; Adipose tissue; Catecholamine; Insulin resistance; Tumor necrosis factor

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADENYLATE CYCLASE; ADENYLATE KINASE; ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 2; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPIDIDYMIS FAT; GENE EXPRESSION; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; UPREGULATION;

3T3-L1 CELLS; ADENYLATE CYCLASE; ADIPOCYTES; ADIPONECTIN; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; ENZYME ACTIVATION; ETHANOLAMINES; FENOTEROL; FORSKOLIN; GENE EXPRESSION REGULATION; ISOPROTERENOL; ISOQUINOLINES; MALE; MICE; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 34547429074     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.005     Document Type: Article

References (42)

1. Bauche I.B., Ait El Mkadem S., Rezsohazy R., Funahashi T., Maeda N., Miranda L.M., and Brichard S.M. Adiponectin downregulates its own production and the expression of its AdipoR2 in transgenic mice. Biochem. Biophys. Res. Commun. 345 (2006) 1414-1424
2. Beylot M., Pinteur C., and Peroni O. Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Metabolism 55 (2006) 396-401
3. Blüher M., Windgassen M., and Paschke R. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care 23 (2000) 1591-1592
4. Boone A.N., Rodrigues B., and Brownsey R.W. Multiple-site phosphorylation of the 280 kDa isoform of acetyl-CoA carboxylase in rat cardiac myocytes: evidence that cAMP-dependent protein kinase mediates effects of β-adrenergic stimulation. Biochem. J. 341 (1999) 347-354
5. Cohen P., and Hardie D.G. The actions of cyclic AMP on biosynthetic processes are mediated indirectly by cyclic AMP-dependent protein kinase. Biochim. Biophys. Acta 1094 (1991) 292-299
6. Delporte M.L., Funahashi T., Takahashi M., Matsuzawa Y., and Brichard S.M. Pre- and Post-translational negative effect of β-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem. J. 367 (2002) 677-685
7. Dyck J.R., Kudo N., Barr A.J., Davies S.P., Hardie D.G., and Lopaschuk G.D. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5′-AMP activated protein kinase. Eur. J. Biochem. 262 (1999) 184-190
8. Facchini F.S., Stoohs R.A., and Reaven G.M. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am. J. Hypertens. 9 (1996) 1013-1017
9. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 507 (2001) 142-146
10. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 290 (2002) 1084-1089
11. Fasshauer M., Klein J., Kralisch S., Klier M., Lössner U., Blüher M., and Paschke R. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett. 558 (2004) 27-32
12. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., and Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2005-2010
13. Fu Y., Luo N., Klein R.L., and Garvey W.T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J. Lipid Res. 46 (2005) 1369-1379
14. Gaidhu M.P., Fediuc S., and Ceddia R.B. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated gluose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J. Biol. Chem. 281 (2006) 25956-25964
15. Hoieggen A., Fossum E., Nesbitt S.D., Palmieri V., and Kjeldsen S.E. Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica. Blood Press. 9 (2000) 83-90
16. Hotamisligil G.S. The role of TNF-α and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245 (1999) 621-625
17. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
18. Hotamisligil G.S., Budavari A., Murray D., and Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94 (1994) 1543-1549
19. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271 (1996) 665-668
20. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
21. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116 (2006) 1784-1792
22. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
23. Koh H.J., Hirshman M.F., He H., Li Y., Manabe Y., Balschi J.A., and Goodyear L.J. Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. Biochem. J. 403 (2007) 473-481
24. Lafontan M., and Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights?. Trends Pharmacol. Sci. 24 (2003) 276-283
25. Long Y.C., and Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116 (2006) 1776-1783
26. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., and Matsuzawa Y. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001) 2094-2099
27. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furayama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., and Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
28. Maison P., Byrne C.D., Hales C.N., and Wareham N.J. Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous system and the metabolic syndrome?. Metabolism 49 (2000) 81-87
29. Moule S.K., and Denton R.M. The activation of p38 MAPK by the β-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439 (1998) 287-290
30. Nguyen M.T., Satoh H., Favelyukis S., Babendure J.L., Imamura T., Sbodio J.I., Zalevsky J., Dahiyat B.I., Chi N.W., and Olefsky J.M. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 35361-35371
31. Nielsen J.N., and Richter E.A. Regulation of glycogen synthase in skeletal muscle during exercise. Acta Physiol. Scand. 178 (2003) 309-319
32. 3-adrenoceptor agonist. Eur. J. Pharmacol. 518 (2005) 71-76
33. Reaven G.M., Lithell H., and Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334 (1996) 374-381
34. Tsuchida A., Yamauchi T., Ito Y., Hada Y., Maki T., Takekawa S., Kamon J., Kabayashi M., Suzaki R., Hara K., Kubota N., Yerauchi Y., Froguel P., Nakae J., Kasaga M., Accili D., Tobe K., Ueki K., Nagai R., and Kadowaki T. Insulin/foxol pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279 (2004) 30817-30822
35. Tsuchida A., Yamaushi T., Takekawa S., Hada Y., Ito Y., Maki T., and Kadowaki T. Peroxisome proliferator-activated receptor (PPAR) α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ and their combination. Diabetes 54 (2005) 3358-3370
36. Waki H., Yamauchi T., Kamon J., Kita S., Ito Y., Hada Y., Uchida S., Tsuchida A., Takekawa S., and Kadowaki T. Generation of globular fragment of adiponection by leukocyte elastase secrected by monocytic cell line THP-1. Endocrinology 146 (2005) 790-796
37. Watt M.J., Holmes A.G., Pinnamaneni S.K., Garnham A.P., Steinberg G.R., Kemp B.E., and Febbraio M.A. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol., Endocrinol. Metab. 290 (2006) E500-E508
38. Winder W.W., Wilson H.A., Hardie D.G., Rasmussen B.B., Hutber C.A., Call G.B., Clayton R.D., Conley L.M., Yoon S., and Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activation protein kinase and protein kinase A. J. Appl. Physiol. 82 (1997) 219-225
39. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001) 941-946
40. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
41. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., and Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
42. Yin W., Mu J., and Birnbaum M.J. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 278 (2003) 43074-43080